Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin

Clinical trial NCT00634192 · COMPLETED

Trial details

NCT number: NCT00634192
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pseudomonas Infections

Start date: 2008-02-01
Primary completion: 2009-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.